Atlas Trials

Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon

Clinical trial NCT00419419 · COMPLETED

Trial details

NCT number
NCT00419419
Sponsor
MediQuest Therapeutics
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Raynaud's DiseaseSclerodermaAutoimmune Diseases
Start date
2006-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.